Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose atorvastatin for prevention of cardiovascular complications after non-cardiac surgery
IRCT20240825062861N1Phase 3Completed
- Sponsor
- Aja University of Medical Sciences
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cardiovascular complications comparing High-dose atorvastatin with Placebo (2 arms). Primary endpoint: High sensitivity troponin. Started Sep 2024; status: completed.
02
Drugs
atorvastatin
03
Conditions
cardiovascular complications
Beyond the preview
Go deeper on IRCT20240825062861N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240825062861N1.